Hydrocodone Withdrawal: Symptoms, Timeline and Treatment

Hydrocodone withdrawal can begin within about 8 to 12 hours after the last dose in a physically dependent person using a short-acting formulation, often becomes most intense around 36 to 72 hours, and then gradually improves over the next several days. Common symptoms include restlessness, anxiety, yawning, sweating, watery eyes, runny nose, muscle aches, enlarged pupils, abdominal cramps, nausea, vomiting, diarrhea, insomnia and strong opioid cravings.

Current hydrocodone labeling warns against rapid dose reduction or abrupt discontinuation in people who may be physically dependent. Sudden discontinuation can cause serious withdrawal, uncontrolled pain and psychological distress, and has been associated with attempts to obtain opioids from unsafe sources.

Opioid withdrawal is usually not directly life-threatening in the way severe alcohol or benzodiazepine withdrawal can be, but it can still become medically serious. Repeated vomiting or diarrhea can cause dehydration, co-occurring medical or psychiatric conditions can destabilize, and return to opioid use after tolerance falls can lead to overdose.

Hydrocodone Withdrawal at a Glance

Why Hydrocodone Withdrawal Happens

Hydrocodone activates mu-opioid receptors. With repeated exposure, the nervous system adapts to the continuing opioid effect. This adaptation is physical dependence.

When hydrocodone is suddenly removed or sharply reduced, the nervous system temporarily shifts toward increased autonomic activity. Sweating, yawning, runny nose, enlarged pupils, anxiety, muscle aches, gastrointestinal symptoms and insomnia are all part of that rebound state.

Physical dependence can develop during medically appropriate treatment. It can also occur alongside misuse or opioid use disorder. The presence of withdrawal by itself does not establish addiction.

Early Hydrocodone Withdrawal Symptoms

With short-acting hydrocodone, early symptoms can begin within hours after the last dose. The exact onset varies with formulation, duration of use, total exposure, liver function and use of other opioids.

• Restlessness
• Anxiety or irritability
• Yawning
• Watery eyes
• Runny nose
• Sweating
• Chills or gooseflesh
• Muscle aches
• Back or joint pain
• Difficulty sleeping
• Enlarged pupils

Some people first notice that they feel unusually anxious, achy, sweaty or unable to sleep before nausea, vomiting or diarrhea become prominent.

Later Symptoms as Withdrawal Intensifies

Gastrointestinal and autonomic symptoms often become more noticeable as withdrawal progresses toward its peak.

• Abdominal cramping
• Nausea
• Vomiting
• Diarrhea
• Loss of appetite
• Weakness
• Rapid breathing
• Fast heartbeat
• Increased blood pressure
• Strong opioid cravings

Repeated vomiting and diarrhea can lead to dehydration and electrolyte problems. Older adults, pregnant patients and people with significant heart, kidney or other medical conditions may tolerate fluid loss poorly.

Hydrocodone Withdrawal Timeline

Clinical reviews group hydrocodone with short-acting opioids. A common pattern begins within roughly 8 to 12 hours, reaches its greatest intensity over the next one to three days and then gradually eases.

This is a population-level pattern, not a personal countdown. Extended-release hydrocodone can have a different onset and course. Repeated use of other opioids can also change the timeline.

How Long Does Hydrocodone Withdrawal Last?

For short-acting opioids such as hydrocodone, the most intense physical symptoms often improve within roughly four to seven days. Some references use a broader four-to-ten-day window for short-acting opioid withdrawal.

Sleep problems, low mood, low energy and cravings can remain after diarrhea, sweating and muscle aches improve. The persistence of these symptoms depends on the duration and intensity of opioid exposure, psychiatric health, pain, sleep and the person’s environment.

A return of craving after the acute phase is clinically important because tolerance may already be lower even though the desire to use remains strong.

What Makes Withdrawal More Severe?

• Longer duration of hydrocodone use
• Higher total opioid exposure
• Immediate-release or extended-release formulation
• Use of additional opioids
• Previous withdrawal episodes
• Medical or psychiatric conditions
• Concurrent alcohol or benzodiazepine use
• Sleep deprivation or dehydration
• Pregnancy
• Limited medical or social support

A person who believes they are taking hydrocodone from an illicit source may also be exposed to fentanyl or another opioid, which can produce a different withdrawal pattern and a substantially different overdose risk.

Hydrocodone Withdrawal vs. Opioid Overdose

Withdrawal usually involves an overactive nervous system with sweating, restlessness, diarrhea, enlarged pupils, aches and insomnia. Opioid overdose involves excessive opioid effect.

Warning signs of overdose include profound sleepiness, inability to wake, slow or stopped breathing and loss of consciousness.

If someone cannot be awakened or is breathing slowly or abnormally, treat the situation as possible overdose. Give naloxone if available and call emergency services. Do not assume that an unresponsive person is simply exhausted from withdrawal.

Why Overdose Risk Can Rise After Withdrawal

Opioid tolerance can fall during abstinence. A person who returns to an amount they previously used may therefore receive a much stronger opioid effect than expected.

This loss of tolerance is one of the most important risks after detoxification or a period without opioids. Counterfeit tablets increase the danger further because a pill sold as hydrocodone may contain fentanyl or another high-potency opioid.

Naloxone access and a continuing treatment plan remain important after the acute withdrawal symptoms have ended.

Should Hydrocodone Be Stopped Suddenly?

Current U.S. hydrocodone labeling advises against rapid reduction or abrupt discontinuation in patients who may be physically dependent. Rapid discontinuation has been associated with serious withdrawal symptoms, uncontrolled pain, psychological distress and attempts to obtain opioids from unsafe sources.

There is no universal dose-by-dose taper that is appropriate for every patient. A taper has to account for the amount being taken, duration of treatment, pain condition, physical and psychiatric health, withdrawal symptoms and whether opioid use disorder is present.

Someone taking prescribed hydrocodone regularly should involve the prescribing clinician before changing the regimen. A person using non-prescribed opioids may need an opioid-use-disorder assessment instead of a simple pain-medication taper.

What Happens if a Taper Causes Withdrawal?

Withdrawal symptoms during an opioid taper can indicate that the reduction is moving faster than the person’s nervous system is tolerating. CDC guidance recommends considering a slower or paused taper when clinically significant withdrawal develops.

Clinicians can also use symptom-targeted medications when appropriate. Alpha-2 adrenergic agonists such as clonidine or lofexidine can reduce autonomic symptoms in opioid withdrawal, while other treatments may be used for nausea, diarrhea, aches or sleep problems.

Medication selection depends on blood pressure, other prescriptions, medical history and the overall treatment plan. It should not be assembled from a generic internet regimen.

How Hydrocodone Withdrawal Is Assessed

Clinicians review the opioid history, timing of the last dose, formulation, current symptoms, vital signs, other substances and relevant medical and psychiatric conditions.

The Clinical Opiate Withdrawal Scale, or COWS, is commonly used in treatment settings to describe opioid-withdrawal severity. It combines symptoms and observable signs such as pulse, sweating, restlessness, pupil size, aches, runny nose, gastrointestinal symptoms, tremor, yawning, anxiety and gooseflesh.

Assessment also checks for problems that can resemble withdrawal, including infection, gastroenteritis, medication effects, panic, intoxication and withdrawal from alcohol or benzodiazepines.

Buprenorphine for Hydrocodone-Related Opioid Use Disorder

Buprenorphine is an evidence-based medication for opioid use disorder. It can reduce opioid withdrawal and cravings and lower the reinforcing effects of other opioids.

Starting buprenorphine after recent full-opioid-agonist exposure requires clinical timing because starting it before sufficient withdrawal has developed can precipitate a sudden worsening of withdrawal. Current clinical guidance uses the person’s opioid exposure and withdrawal severity to determine when initiation is appropriate.

A fixed start time or dose cannot account for every hydrocodone formulation, additional opioid or individual medical factor.

Methadone and Naltrexone

Methadone is another evidence-based medication for opioid use disorder. It is a long-acting full opioid agonist that can suppress withdrawal and craving when provided through an appropriate treatment program.

Naltrexone is an opioid antagonist. It is used only after opioids have cleared sufficiently and physiologic dependence has resolved enough to avoid precipitated withdrawal. It does not manage active opioid dependence in the same way buprenorphine or methadone can.

SAMHSA identifies buprenorphine, methadone and naltrexone as medications used for opioid use disorder involving semisynthetic opioids such as hydrocodone.

Detox Is Not the Same as Treatment for Opioid Use Disorder

Withdrawal management can help a person get through acute symptoms safely, but completing detoxification does not resolve the underlying opioid use disorder when one is present.

The period after detox can carry high risk because cravings may continue while tolerance has fallen. Evidence-based treatment may include medication for opioid use disorder, behavioral care, naloxone, psychiatric treatment, pain management and social support.

Depending on medical and psychiatric needs, care may involve detox services, residential treatment or dual-diagnosis treatment.

Can Hydrocodone Withdrawal Be Managed at Home?

Some patients taper prescribed hydrocodone as outpatients with clinical supervision. That can still mean being at home while following a medical plan.

More structured care may be appropriate for severe withdrawal, repeated relapse, pregnancy, unstable medical illness, suicidal thinking, unsafe housing, significant opioid use disorder or dependence on alcohol, benzodiazepines or other drugs.

Someone who cannot keep fluids down, becomes faint or confused, or has another serious medical symptom needs assessment instead of assuming the problem can be managed at home.

Hydrocodone Combination Pills Add Acetaminophen Risk

Many common hydrocodone tablets contain acetaminophen. Examples include legitimate M365, T257, M366, M367 and IP 110 tablets.

Hydrocodone is the component responsible for opioid dependence and withdrawal. Acetaminophen does not cause opioid withdrawal, but excessive acetaminophen exposure can injure the liver.

A person who has been taking large quantities of combination tablets may therefore need assessment for two separate issues: opioid dependence and possible acetaminophen toxicity.

Does Hydrocodone Withdrawal Mean Addiction?

No. Withdrawal demonstrates physical dependence. A patient can become physically dependent while taking hydrocodone exactly as prescribed.

Opioid use disorder is diagnosed from a broader pattern that can include craving, loss of control, taking more than intended, unsuccessful efforts to cut down, hazardous use and continued use despite harm.

Hydrocodone Addiction covers dependence, tolerance and opioid use disorder in more detail.

Alcohol, Benzodiazepines and Other Withdrawal Risks

Polysubstance use changes the safety assessment. Alcohol and benzodiazepines can cause potentially life-threatening withdrawal syndromes with seizures or delirium in physically dependent people.

A person stopping hydrocodone, heavy alcohol use and benzodiazepines at the same time may have overlapping symptoms from several withdrawal syndromes. Medical care should identify each substance instead of attributing everything to hydrocodone.

Hydrocodone also carries serious respiratory-depression risk when combined with alcohol or benzodiazepines during active use.

Pregnancy and Hydrocodone Dependence

Pregnancy requires specialized medical care when opioid dependence or opioid use disorder is present. Abrupt opioid discontinuation should not be attempted without obstetric and addiction-treatment guidance.

Medication treatment for opioid use disorder is commonly used during pregnancy because repeated withdrawal and return to opioid use can create risks for both the pregnant patient and the fetus.

Anyone who is pregnant and physically dependent on hydrocodone should contact an obstetric clinician or addiction-treatment professional before changing opioid use.

When Hydrocodone Withdrawal Needs Urgent Medical Care

• Inability to keep fluids down with signs of severe dehydration
• Fainting or collapse
• Severe confusion
• Chest pain
• Seizure
• Suicidal thoughts with immediate danger
• Pregnancy complications
• Severe symptoms after stopping alcohol or benzodiazepines
• Any other rapidly worsening medical condition

If the person is difficult to wake or has slow, irregular or stopped breathing, treat the situation as an opioid overdose. Give naloxone if available and call 911.

Frequently Asked Questions About Hydrocodone Withdrawal

How soon can hydrocodone withdrawal begin?

With short-acting hydrocodone, symptoms can begin within about 8 to 12 hours after the last dose in a physically dependent person. Timing varies by formulation and individual factors.

When is hydrocodone withdrawal usually most intense?

Clinical reviews of short-acting opioids describe peak withdrawal intensity around 36 to 72 hours after cessation.

What is the usual duration of acute hydrocodone withdrawal?

Many acute physical symptoms improve over roughly four to seven days, although some references use a broader four-to-ten-day range and cravings or sleep problems can last longer.

Can hydrocodone withdrawal cause seizures?

Seizure is not a typical feature of uncomplicated opioid withdrawal. A seizure requires emergency evaluation for another drug, withdrawal syndrome or medical condition.

Is hydrocodone withdrawal dangerous?

It can cause dehydration and medical destabilization. The period after withdrawal is also dangerous because opioid tolerance may fall while cravings continue.

Should prescribed hydrocodone be stopped suddenly?

Current labeling advises against rapid reduction or abrupt discontinuation in a physically dependent patient. Dose reduction should be individualized with the treating clinician.

What medications treat hydrocodone-related opioid use disorder?

Buprenorphine, methadone and naltrexone are evidence-based medications for opioid use disorder. The appropriate medication and initiation plan depend on clinical assessment.

Does hydrocodone withdrawal prove someone is addicted?

No. Withdrawal demonstrates physical dependence. Opioid use disorder requires a broader pattern of impaired control and harmful use.

Sources

• DailyMed: Hydrocodone Bitartrate and Acetaminophen: current 2026 labeling on physical dependence, withdrawal and safe dose reduction.
• MedlinePlus: Hydrocodone: current withdrawal symptoms, abrupt-discontinuation warning and opioid-overdose guidance.
• Kosten and Baxter: Effective Management of Opioid Withdrawal Symptoms: short-acting opioid withdrawal timing, symptoms and treatment principles, including hydrocodone.
• CDC Clinical Practice Guideline for Prescribing Opioids for Pain: tapering, management of withdrawal symptoms and transition to buprenorphine.
• SAMHSA: Treatment Options for Substance Use Disorder: buprenorphine, methadone and naltrexone for opioid use disorder involving hydrocodone.
• DSM-5 Opioid Withdrawal Syndrome in Adults With Nonmedical Prescription Opioid Use: epidemiologic context and timing of withdrawal after short-acting analgesics such as hydrocodone.